SOURCE: annual_report_text (1).txt
CHUNK: 212 of 1106
SIZE: 580 characters
PREVIOUS: chunk_0211_annual_report_text (1).txt
NEXT: chunk_0213_annual_report_text (1).txt
------------------------------
2023, IBA 
successfully 
launched 
a 
next-generation 
reference class electrometer DOSE-X, which 
has already reached sales of more than 300 
units. In May at ESTRO, IBA launched a 
radiation oncology risk management software 
called myQA PROactive, alongside updates to 
existing patient QA software. Post period end, IBA announced the acquisition 
of US-based Radcal Corporation, a pioneer in X-
ray imaging quality assurance. The acquisition is 
anticipated to be revenue accretive and EBIT 
positive from 2024 onwards and will further 
strengthen Dosimetrys product offering.